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Introduction
The prevalence of overweight and obesity varies in populations and is estimated to range from 5% in some developing countries to .30% in obesity related subfertility can be anticipated in the future (Schokker et al., 2007) . Nowadays, the rate of obesity in women of child bearing age is 12% in Western Europe and 25% in North America (Butler, 2004; Linné, 2004; Haslam and James 2005; Watson, 2005) .
The strongest obesity related effect on fertility is anovulation. Polycystic ovarian syndrome (PCOS), the most noted cause of anovulation, is furthermore exacerbated by increased insulin resistance and hyperinsulinemia associated with overweight and obesity (Pasquali et al., 2007) . In 65% of patients with PCOS, obesity therefore contributes to anovulation (Pasquali et al., 2003) . On the other hand, even obese women with an ovulatory cycle have a lower chance of spontaneous conception (Jensen et al., 1999; Van der Steeg et al., 2007) .
In cases of chronic anovulation, ovulation induction (OI) with clomiphene citrate in overweight and obese women results in lower ovulation rates (Imani et al., 1998) and lower cumulative live birth rates for women with a BMI . 30 kg/m 2 (Legro et al., 2007) . McClure et al. (1992) showed that in overweight women ovulation rates are lower due to higher cancellation rates, but if OI is successful no difference is found in pregnancy rates in different weight categories. Mulders et al. (2003) also found obesity to be associated with higher cancellation rates and substantially higher miscarriage rates leading to a lower live birth rate per started cycle. This decreased success rate is however not found in all studies .
The literature on the impact of body weight on the effectiveness of intrauterine insemination (IUI) is just as for OI, inconsistent. Koloszar et al. showed a negative impact of increasing body weight on the success rates of IUI, but Wang et al. (2004) could not confirm this finding.
Furthermore, several retrospective studies have shown a negative impact of overweight and obesity in women on the outcome of in vitro fertilization (IVF) (Lashen et al., 1999; Wang et al., 2000; Koloszar et al., 2002; Fedorcsak et al., 2004) . The ongoing pregnancy rate and live birth rate is however consistently decreased especially due to an increased miscarriage rate in women with obesity (Wang et al., 2002; Lintsen et al., 2005; Maheshwari et al., 2007) .
Apart from these obesity related fertility problems, there is indisputable evidence that pregnancy in overweight and obese women is associated with an increased risk of complications, leading to higher maternal and neonatal morbidity and mortality and increased costs (Cedergren, 2004; Linné, 2004; Sebire et al., 2001) . Pregnancy complications associated with obesity are hypertensive disorders, gestational diabetes, prolonged duration of labour, increased need of operative delivery, macrosomia, shoulder dystocia and increased blood loss (Garbaciak et al., 1985; Edwards et al., 1996; Weiss et al., 2004) . Obesity is furthermore associated with an increased risk of adverse pregnancy outcomes such as unexplained stillbirth (Cnattingius et al., 1998; Linné, 2004; Kristensen et al., 2005) and neonatal admissions (Usha Kiran et al., 2005) .
In view of the issues stated above, it is likely that overweight and obesity have a negative impact on the outcome as well as the costs of fertility treatment. The aim of this article is to conceptualize the impact of overweight and obesity on fertility treatment and the resultant pregnancies, in terms of effectiveness, costs and cost-effectiveness.
Methods
We developed a framework within which the consequences of fertility treatment and outcomes of resultant pregnancy can be evaluated simultaneously for subfertile women in different body weight categories. We performed systematic reviews to obtain information on outcomes and costs to generate cost-effectiveness estimates for inclusion in decision analytic models. To do so, we searched the literature for evidence on the effect of obesity on spontaneous pregnancy chances, success of assisted reproduction technologies (ART), as well as pregnancy outcome.
We used the following electronic databases: PubMed, Embase, DARE and the Cochrane Library to initially search for systematic reviews on each of the subjects. In absence of reviews, we identified large, reliable studies.
To identify studies that reported on the association between obesity and spontaneous pregnancy chances we combined the key words ('obesity', 'overweight' or 'BMI') and ('pregnancy' or 'fertility') . By adding the key words ('ART', 'IUI') and ('OI') we looked for studies reporting on the effect of obesity on these treatments. To identify studies reporting on the association between obesity and pregnancy outcome, we used the key words: ('obesity', 'overweight' or 'BMI') and ('pregnancy outcome').
We included studies reporting on maternal morbidity as well as pregnancy outcome. The reported odds ratios (ORs) in the reviews were used, or if not available, calculated by using a 2 Â 2 table cross classifying BMI and one of the aforementioned outcomes. These ORs were used as input for calculating the additional impact of overweight and obesity on both fecundity as well as pregnancy.
The economic analysis was performed from a hospital perspective. Costs of fertility treatments were obtained from a series of Dutch studies, which reported on the costs of OI, IUI and costs of IVF (Goverde et al., 2000; Eijkemans et al., 2005) . Furthermore, we looked for studies reporting on costs of pregnancy in overweight women and costs of pregnancy complications in these women. To do so, we performed a search of several major journals in obstetrics and gynaecology for economic evaluations. We looked for studies that reported on the costs of each of the complications miscarriage, pre-eclampsia, gestational diabetes and Caesarean delivery. We assumed no difference in multiple pregnancy rates between different weight categories (Esinler et al., 2008) .
Next, we assessed the impact of overweight and obesity on the costs and effects of fertility treatments. To achieve this, we distinguished between the case of ovulatory women and the case of anovulatory women. For each of these situations, we considered women with normal weight, overweight and obese women. According to the WHO normal weight is defined as a BMI between 20 and 25 kg/m 2 , overweight as a BMI between 25 and 30 kg/m 2 and obesity as a BMI over 30 kg/m 2 . Because of differences in definitions of overweight and obesity in some studies we used in our review, we could not use the very strict BMI cut off points proposed by the WHO for our different weight groups.
We then constructed a theoretical model, simulating the situation where women were treated for their subfertility. For each of the six categories, i.e. anovulatory women with normal weight, anovulatory overweight women and anovulatory obese women and ovulatory women with normal weight, ovulatory overweight women and ovulatory obese women, we calculated the expected pregnancy rates, the expected number of fertility treatments and the expected number of pregnancy complications for a hypothetical group of 1000 women. We performed multiple sensitivity analyses on the following variables success rate of IVF (range 40 -60%), success rate of OI (range 70-90%) and IUI (range 30 -50%). With these figures we calculated and then plotted in two figures different success rates of ART against the costs per live birth in anovulatory and ovulatory women in different weight categories.
Results

Literature identified
The search for studies on the association between spontaneous pregnancy chances in overweight women revealed two reviews by Jensen et al. (1999) and Gesink Law et al. (2007) as well as the study of Van der Steeg et al. (2007) . The results of these studies are shown in Table I . Both reviews as well as the study of Van der Steeg et al. showed that overweight women take longer to conceive than normal weight women. The reviews were retrospective studies in a cohort of women not seeking medical help for any subfertility, whereas Van der Steeg et al. studied women in fertility clinics. On the basis of these results, we assumed that among obese ovulatory women spontaneous pregnancy chances were 90% of those in normal weight or overweight women. Moreover, we assumed that spontaneous pregnancy chances prior to and in between ART cycles was 10% in all groups.
From the literature no unequivocal conclusion could be drawn about the influence of obesity on IUI. Whereas Wang et al. (2004) reported an increased probability of success of IUI in women with a BMI . 30 kg/m 2 , Koloszar et al. reported exactly the opposite, i.e. a decrease of success of IUI with increasing BMI. In view of these conflicting results on IUI, for purpose of this review we considered no effect of BMI on IUI. Maheshwari et al. (2007) published a systematic review of the literature from 1960 until 2006 on the outcome of IVF for overweight and obese women. They reported an OR for pregnancy after IVF of 0.71 (CI 95% 0.62-0.81) for women with a BMI . 25 kg/m 2 compared with women with a BMI between 20 and 25 kg/m 2 , and for women with a BMI . 30 kg/m 2 even 0.68 (CI 95% 0.55-0.83) (Table I) . We applied these ORs in our model. Maheshwari et al. (2007) also found that overweight women require more total units of gonadotrophins during hyperstimulation for IVF, but these additional costs were not considered in the present analysis.
We found one meta-analysis and three studies that reported on the impact of BMI on the effectiveness of OI in anovulatory women (Table II) (Imani et al., 2002; Al-Azemi et al., 2004; Mulders et al., 2003; Balen et al., 2006) . The study of Al-Azemi et al. showed a negative impact of obesity on live birth rate after OI with clomiphene citrate. The meta-analysis of Mulders et al. did not show a significant impact of BMI on the fecundity after OI with gonadotrophins. However, they found higher cancellation rates per cycle (OR 1.9) and higher miscarriage rates in the obese group (OR 3.1), thus leading to lower ongoing pregnancy rates per started cycle.
Balen et al. studied anovulatory women with a BMI up to 35 kg/m 2 and also did not find a significant difference in pregnancy rates after OI with gonadotrophins in overweight and obese women compared with women of normal weight . Imani et al. found among anovulatory women a hazard ratio of 0.92 for obese versus lean women for ovulation after OI with clomiphene citrate, but they also did not find a difference in live birth chances between the weight groups (Imani et al., 2002) . We therefore assumed in our analysis that there is no influence of BMI on pregnancy rates after OI in anovulatory women. Table III shows the additional risk of obstetric complications due to overweight and obesity. We applied meta-analyses conducted by Chu et al. (2007a, b, c) and Cnossen et al. (2007) . These studies report that there is an additional risk of stillbirth, Caesarean delivery, preeclampsia and gestational diabetes with increasing BMI. Fedorcsak et al. (2004) Table IV presents expected costs of fertility treatment and pregnancy complications. We used several studies on costs of pregnancy complications and calculated the costs presented in euro's using the current exchange rates (Chen et al., 2001; Graziosi et al., 2005; Barton et al., 2006; Moss et al., 2007) . Furthermore, we used studies on costs in the Netherlands for OI, IUI and IVF treatment (Goverde et al., 2000; Eijkemans et al., 2005) . Table V shows the result when the model was applied on a hypothetical cohort of 1000 anovulatory women. Our model represents costs until birth, including the costs of delivery. In 1000 normal weight anovulatory women, treatment with three cycles of OI and, if needed, followed by one or two cycles of IVF, would result in 900 pregnancies. Figure 1A shows that costs per live birth are higher for overweight and obese anovulatory women with different success rates of OI and IVF and these differences in costs are roughly constant over a large range of success rates.
Expected outcome and costs
Of these pregnancies 90 are expected to end in miscarriage and 810 women will have an ongoing pregnancy. The expected number of pregnancies complicated by pre-eclampsia, gestational diabetes and Caesarean delivery, will be 81, 41 and 81, respectively, whereas four women will suffer stillbirth. Overall, 806 women are expected to deliver a child, for a total cost of E2430 per woman, resulting in a cost of E3016 per live birth.
From decrease of the number of pregnancies and live births, an increase in costs and a relative increase of the number of complications. This results in a decrease in the number of live births of 114 (14%), and an expected increase in costs of almost E800 (32%) per patient. For obese anovulatory women, these figures are slightly worse, as the number of live births decrease to 119 (15%), and the expected increase in cost of approximately E1700 (71%) per patient as compared with normal weight women. Table VI shows the results for a theoretical cohort of 1000 ovulatory women. In 1000 normal weight ovulatory women, treatment consisted of three cycles of IUI and if this was unsuccessful one or two cycles of IVF, added with 10% spontaneous pregnancies that occur on waiting lists or in between cycles, would result in 780 pregnancies. Figure 1B show that over a large range of different success rates of IUI and IVF the costs per live birth are higher for overweight and obese ovulatory women.
Of these pregnancies 78 are expected to suffer a miscarriage and 702 women will have an ongoing pregnancy. The expected number of pregnancies complicated by pre-eclampsia, gestational diabetes and Caesarean delivery, will be 70, 35 and 70, respectively, whereas four women will suffer stillbirth. Overall, 698 women are expected to deliver a child, for a total cost of E4258 per woman, resulting in a cost per live birth E6096.
Similarly as for anovulatory women, it can be shown that in overweight ovulatory women the effectiveness of treatment decreases, resulting in a decrease of the number of pregnancies and live births, an increase in costs and a relative increase of the number of complications. This results in a decrease in the number of live births of 153 (22%), with the expected increase in costs of E543 (13%), resulting in a cost per live birth of E8800. For obese ovulatory women, these figures are worse with a decrease in live births of 167 (24%), with the expected increase in costs of almost E1250 (29%), resulting in a cost per live birth of E10 355.
Discussion
Overweight and obesity are an increasing problem in Western society. In this review, we collected data on the impact of overweight and obesity on fertility care. We found that both in ovulatory and in anovulatory subfertile women overweight and obesity resulted in a decreased fecundity and in an increase in the number of pregnancy complications and associated costs. However, there is no proven cause and effect between overweight and subfertility. It remains possible that excessive weight and subfertility are both symptoms of an unknown pathology.
Our results roughly suggest that overweight leads to an additional cost of E1500 per pregnancy and 100 fewer pregnancies per 1000 anovulatory women undergoing fertility treatment, where this is E2500 and 150 pregnancies, respectively, for anovulatory women.
The validity of our findings depends on the robustness of our methodology. We put forward a framework that can be used to encourage development of more advanced models for generating costeffectiveness information through robust economic evaluation. In our review of the literature, we found different and occasionally conflicting results on the impact of overweight and obesity on the effect of fertility treatment. When this was the case, we chose to consider no effect of overweight. Furthermore the success rate of IVF decreases with increasing BMI (Maheshwari et al., 2007) , thus overweight and obese women will have to undergo more cycles compared with normal weight women.
As a consequence, our findings may be an underestimation of the impact of overweight and obesity. Since the purpose of this review was not to give exact figures on costs but to show a trend in costs and cost-effectiveness, we feel this possible inaccuracy does not undermine the overall conclusion.
From our analysis several issues rise. First, as a higher BMI is associated with more pregnancy complications, there is the question as to whether women should lose weight before fertility treatment is started. A recent retrospective analysis by Maheshwari et al. (2009) concludes that cost of IVF is not different for several weight categories but because of obstetric complications associated with higher BMI women with overweight should be advised to lose weight prior to IVF. Our analysis concurs with this conclusion and gives indicative results that merit consideration in counselling patients and guiding evidence-based discussions on current practice and policy.
Weight loss may be achieved by lifestyle modification interventions, incorporating multiple approaches (diet, exercise, behaviour) . Interventions of this kind are advised as a key component for the Economic consequences of overweight and obesity in infertility improvement of reproductive function in overweight women, specifically with PCOS (Kiddy et al., 1992; Clark et al., 1995 Clark et al., , 1998 Huber-Buchholz, 1999; Hoeger et al., 2004; Norman et al., 2004; Balen et al., 2006; Tang et al., 2006) , although the evidence of its effectiveness as demonstrated in clinical studies is limited. The costeffectiveness of losing weight has never been assessed in large groups of subfertile women with respect to increasing treatment success for weight-related subfertility, prevention of complications during pregnancy and improvement of perinatal outcome. Until this has been demonstrated we do not think it should be obligatory for overweight subfertile women to undergo a lifestyle intervention programme before starting fertility treatment but in counselling patients there should be attention for possible pregnancy complications with increasing BMI. It is clear that losing weight takes great effort and we feel that overweight should be considered a disease rather than an amenable condition.
Second, apart from the unproven effectiveness of lifestyle interventions in overweight subfertile women, there is the question as to whether there should be upper limits for BMI above which couples should not be treated. Some authors have suggested limits for BMI for women undergoing fertility treatment, both with the arguments of patient safety concerns, as well as a lack of effectiveness of treatment of obese women (Gillett et al., 2006; Zachariah et al., 2006; Maheshwari et al., 2007) . However, we feel that from the perspective of effectiveness of treatment, our data show that there is no reason to withhold treatment. Although effectiveness rates decrease with increasing BMI, the same appears true for women undergoing assisted reproduction over the age of 40, which is a well accepted practice in many countries. Age is however a predictable and amenable factor considering the fact that many couples delay conception to for example pursue career opportunities. In our opinion, studies on weight loss interventions should show a clear increase of effectiveness of fertility treatment and a clear decrease in pregnancy related complications, before BMI thresholds can be implemented. In conclusion, in ovulatory and anovulatory subfertile women overweight and obesity is associated with a decrease in the number of pregnancies, a sharp increase in the number of complications with an additional rise of associated costs per pregnancy. There is not enough evidence Applied BMI (kg/m 2 ) threshold differed from study to study (range 25 -27).
2 Applied BMI (kg/m 2 ) threshold differed from study to study (range 29 -35).
however to prove that losing weight will improve the outcome of fertility treatment and decrease complications in pregnancies, and therefore strict BMI thresholds cannot be recommended yet. However, overweight and obese subfertile women should be counselled that overweight is a risk factor in pregnancy and is associated with several complications in both mothers and their children.
